Sri Lanka endorses Pfizer COVID-19 vaccine for emergency use Kumar Jeetendra | May 8, 2021 Sri Lanka on Saturday approved Pfizer’s COVID-19 vaccine for emergency use in Sri Lanka, as the island nation battles a third wave of the virus, while suffering a restricted supply of vaccines from neighboring India. Dr. Sudharshani Fernandopulle, the minister overseeing the fight against the epidemic, said in a statement the government would order 5 …
EMA opens audit of China’s Sinovac Covid jab Kumar Jeetendra | May 4, 2021 The European Medicines Agency said Tuesday it has started a “rolling review” of China’s Sinovac coronavirus jab, a process that could lead to eventual approval for the European market. Made by Sinovac’s Beijing-based Life Sciences unit, the vaccine contains an inactivated coronavirus that cannot cause a disease, but helps a person to develop antibodies against …
FDA supports new medication for therapy of adults with chronic kidney infection Kumar Jeetendra | May 1, 2021 Today, the U.S. Food and Drug Administration accepted Farxiga (dapagliflozin) oral tablets to decrease the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. Chronic kidney disease occurs when the kidneys are damaged and can’t filter blood …
Cipla enters into a licensing agreement with MSD to expand access to investigational oral therapeutic drug for COVID-19 treatment Kumar Jeetendra | April 28, 2021 Mumbai, India; April 28, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has signed a non-exclusive licensing agreement with MSD a tradename of Merck & Co., Inc. Kenilworth, NJ., USA for the manufacturing and distribution of Molnupiravir, the investigational oral antiviral drug currently being studied …
Caplin Point Laboratories arm gets USFDA gesture for Neostigmine Methylsulfate Injection Kumar Jeetendra | April 22, 2021 New Delhi: Caplin Point Laboratories on Thursday said its subsidiary has received approval from the US health regulator for Neostigmine Methylsulfate Injection. Neostigmine Methylsulfate Injection is a cholinesterase inhibitor and is indicated for the reversal of the effects of non-depolariSing neuromuscular blocking agents (NMBAs) after surgery. “Caplin Steriles Ltd (Caplin) has been granted final approval …
Johnson and Johnson says in talks with Indian government for preliminary of single-portion vaccine Kumar Jeetendra | April 9, 2021 Johnson & Johnson is in talks with India’s government to start a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday. The U.S. drugs and health care giant’s vaccine is currently approved for use in the USA, the European Union and other countries including Thailand and South Africa. The …
ENPICOM and Viroclinics-DDL receive joint MIT Zuid subsidy to accelerate and improve antibody and vaccine discovery and development Kumar Jeetendra | April 6, 2021 ‘s-Hertogenbosch (The Netherlands) – March 30, 2021 – Life Science Newswire – Viroclinics-DDL, a state-of-the-art Contract Research Organization specialized in molecular diagnostic testing and assay development, and ENPICOM, an innovative bioinformatics software engineering company, announced the approval of their joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application. This R&D partnership project …
Zydus Cadila, Alembic Pharma arms review drugs in US Kumar Jeetendra | March 31, 2021 New Delhi, Mar 30 (PTI) US-based arms of national pharma companies Zydus Cadila and Alembic Pharmaceuticals are recalling one drug each in the US after receiving complaints against the products. Administration of crystallized Acyclovir Sodium Injection, 50 mg/mL has a possibility of life threatening adverse consequences, it added. “To date, Zydus Pharmaceuticals (USA) Inc has …
Pfizer, BioNTech dispatch COVID-19 antibody trial in kids under 12 Kumar Jeetendra | March 26, 2021 Pfizer Inc and German partner BioNTech SE began testing their COVID-19 vaccine in children under 12, with hopes of expanding vaccination to that age range from ancient 2022, the US drugmaker said on Thursday. The first volunteers in the early-stage trial were given their first shots on Wednesday, Pfizer spokesperson Sharon Castillo said. The Pfizer/BioNTech …
Glenmark Pharmaceuticals gets USFDA gesture for conventional antipsychotic drug Kumar Jeetendra | March 24, 2021 Drug firm Glenmark Pharmaceuticals on Wednesday said it has received final approval from the US health regulator because of its generic phenothiazine antipsychotic Chlorpromazine Hydrochloride tablets. “The company has received approval from the United States Food and Drug Administration (USFDA) for Chlorpromazine Hydrochloride tablets USP, in the strengths of 10 mg, 25 mg, 50 mg, …
Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats Kumar Jeetendra | March 23, 2021 March 23, 2021, MUMBAI – Cipla Therapeutics, an affiliate of Cipla Limited (BSE: 500087; NSE: CIPLA EQ; referred to as “Cipla”) and SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market announced entering into a strategic partnership to deliver sustained innovation and access to novel antibacterial drugs, particularly …
Cipla pledges support to ‘Terra Carta’, for a sustainable future Kumar Jeetendra | March 19, 2021 Mumbai; March 19, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that it has pledged support to ‘Terra Carta’, a landmark charter that has been drawn up to put sustainability at the heart of the private sector. The charter is part of HRH The Prince of Wales’ Sustainable Markets …
